Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004492 · ClinicalTrials.gov registry record · Phase 1
Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia
A Phase 1 study, sponsored by University of North Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00004492 is a Phase 1 study that has completed, run by University of North Carolina. The registered enrollment target is 20 participants.
The verdict
NCT00004492, a Phase 1 study, has completed, sponsored by University of North Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Compare the efficacy of hydroxyurea with or without clotrimazole in terms of limiting the severity of anemia and the rate of hemolysis in patients with sickle cell anemia.
Interventions
- DRUG hydroxyurea
- DRUG clotrimazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 1999-10 |
| Est. Completion | 2001-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004492
The ClinicalTrials.gov registry entry for NCT00004492 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which hydroxyurea is the first listed.
NCT00004492 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004492 about?
NCT00004492 is a clinical study titled "Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia". OBJECTIVES: I. Compare the efficacy of hydroxyurea with or without clotrimazole in terms of limiting the severity of anemia and the rate of hemolysis in patients with sickle cell anemia.
What is the current status of trial NCT00004492?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 1999-10. Estimated completion is 2001-09.
What interventions are being tested in trial NCT00004492?
The interventions under investigation include: hydroxyurea (DRUG), clotrimazole (DRUG).
Who is sponsoring clinical trial NCT00004492?
This trial is sponsored by University of North Carolina, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.